Equillium
Biotechnology leveraging deep understanding of immunobiology to develop products for autoimmune and inflammatory disorders. Learn more
Launch date
Employees
Market cap
AUD47.6m
Enterprise valuation
(AUD3m) (Public information from Sep 2024)
Share price
$0.85 EQ
San Diego California (HQ)
Authorizing premium user...